Drug Designing: Open Access
Open Access

High Impact List of Articles

• Reliability of Machine Learning Based Algorithms for Designing Protein Drugs with Enhanced Stability
  Jianwen Fang*

  Editorial: Drug Designing: Open Access

• The Success of Solanezumab Should Drive Renewed Efforts to Develop Small Molecule Anti-Amyloid Agents for Alzheimer's disease Therapy.
  Anthony R White

  Editorial: Drug Designing: Open Access

• Identification of Binding Affinity of TAP Peptides for Development of Fragment based Vaccine from Long neurotoxin 2 [N. naja]
  Sherkhane AS and Gomase VS

  Research Article: Drug Designing: Open Access

• Promising Application of Nanotechnology in Anticancer Drug Delivery
  Maling Gou

  Editorial: Drug Designing: Open Access

• Prodrug Design vs. Drug Design
  Rafik Karaman

  Editorial: Drug Designing: Open Access

• Prodrug Design by Computation Methods: A New Era
  Rafik Karaman

  Editorial: Drug Designing: Open Access

Conference Proceedings

• Synthesis of the optical mesoporous silica nanoparticle for cancer treatment by photodynamic therapy method
  Mehrgan Ghazaeian

  Posters & Accepted Abstracts: Drug Designing: Open Access

• GPCR ligand bias revisited: Opioid receptor deorphanisation guided by in silico docking
  Alison Claire Waterfield

  Scientific Tracks Abstracts: Drug Designing: Open Access

• Targeting of cellular organelles by fluorescent nanoparticles
  Diana Costa

  Posters & Accepted Abstracts: Drug Designing: Open Access

• Cucurbitane derived terpenoidal moieties from under-utilised cucurbits as probable medicinal leads
  Ujjwal Kaushik1, M Ali2 and Vidhu Aeri2

  Posters-Accepted Abstracts: Drug Designing: Open Access

• Determination of the antioxidant and cytotoxic activities of the leaves of artocarpus odoratissimusblanco (Moraceae)
  Mary Camille Castillo, Ocat, M N; Aquino, J A E; Canto, G P B; Capuno, B M P; Cruz, A T F; Din, G C F; Lucero, D G O; Morales, R V D; Pajarillo, J D L; Pesigan, J M A; Yap, J A C, Yap, P M M Kua, M F

  Posters-Accepted Abstracts: Drug Designing: Open Access

• Designing protein-protein interaction modulators: LRH-1 and 14-3-3
  Jessica Holien

  Scientific Tracks Abstracts: Drug Designing: Open Access

Relevant Topics in Pharmaceutical Sciences